Your browser doesn't support javascript.
loading
Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma.
Sethi, Tarsheen K; Kovach, Alexandra E; Grover, Natalie S; Huang, Li-Ching; Lee, Laura A; Rubinstein, Samuel M; Wang, Yang; Morgan, David S; Greer, John P; Park, Steven I; Ann Thompson-Arildsen, Mary; Yenamandra, Ashwini; Vnencak-Jones, Cindy L; Reddy, Nishitha M.
Affiliation
  • Sethi TK; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kovach AE; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Grover NS; Division of Hematology-Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Huang LC; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Lee LA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Rubinstein SM; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Wang Y; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Morgan DS; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Greer JP; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Park SI; Levine Cancer Institute, Charlotte, NC, USA.
  • Ann Thompson-Arildsen M; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Yenamandra A; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Vnencak-Jones CL; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Reddy NM; Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Leuk Lymphoma ; 60(12): 2880-2889, 2019 12.
Article de En | MEDLINE | ID: mdl-31184237
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transduction du signal / Tumeurs du système nerveux central / Facteur de différenciation myéloïde-88 / Récepteur-1 de mort cellulaire programmée / Mutation Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Leuk Lymphoma Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transduction du signal / Tumeurs du système nerveux central / Facteur de différenciation myéloïde-88 / Récepteur-1 de mort cellulaire programmée / Mutation Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Leuk Lymphoma Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique